Awakening in Spine Surgery: A Comparison Between Clinical Signs and Bispectral Index
NCT ID: NCT02174913
Last Updated: 2020-07-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2014-05-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Evaluating Ways of Preventing Patients From Being Awake During High-Risk Surgery and Anesthesia
NCT00281489
The Application and Validation of Triple Drug Response Surface Models on Density Spectral Array in Clinical Anesthesia
NCT05525351
Comparison of Opioid Based and Opioid Free Anaesthesia in Transsphenoidal Surgery
NCT03120234
Reliability of BIS Monitoring in Neurosurgical Patients
NCT01483547
Isoflurane During Cardiopulmonary Bypass
NCT02471950
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Control group will receive fentanyl 1 mcg/kg and then fentanyl infusion 1 mcg/kg/hr and propofol TCI target 3-7 mcg/ml until asleep and then atracurium 0.5 mg/kg was given to facilitate endotracheal intubation. The patients will be ventilated with air:oxygen 1:1 L. The TCI propofol will be adjusted by clinical monitoring. If the patient has minor movement, the propofol TCI will be increased incrementally to 0.5 mcg/ml higher level but if major movement occurs the dose will be increased to1.0 mcg/ml higher. When hypotension occurs, this will be treated by fluid loading 200 ml in 10 min if it is not improved, then ephedrine or norepinephrine will be given and the TCI dose will be decreased by 0.5 mcg/ml lower level but not lower than 3.0 mcg/ml. Hypertension will be treated by fentanyl bolus 0.5 mcg/kg and increasing TCI dose to 0.5 mcg/ml higher level but not more than 7 mcg/ml. If hypertension persist, the nicardipine or diltiazem will be given.
Intervention group receives fentanyl 1 mcg/kg and then fentanyl infusion 1 mcg/kg/hr and propofol by TCI 3-7 mcg/ml until asleep and then atracurium 0.5 mg/kg was given to facilitate endotracheal intubation. The patients will be ventilated with air:oxygen 1:1 L. Propofol will be adjusted by BIS monitoring. If the movement occurs and BIS 40-60, fentanyl 0.5 mcg/kg will be given, BIS \> 60, TCI dose will be increased 0.5 mcg/ml higher level until BIS 40-60. When hypotension occurs, if BIS 40-60, will be treated by load fluid 200 ml in 10 mins, then ephedrine or norepinephrine will be given, If BIS \< 40 the TCI dose will decrease 0.5 mcg/ml but not lower than 3.0 mcg/ml. Hypertension occurs, if BIS \> 60 will be treated by fentanyl bolus 0.5 mcg/kg and TCI dose will be increased 0.5 mcg/ml higher level but not more than 7 mcg/ml if not improved, nicardipine or diltiazem will be given. if BIS 40-60, nicardipine or diltiazem will be given.
This outcome measures are extubation time,total propofol dose.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bispectral index/TCI propofol/fentanyl
Bispectral index guides the target controlled infusion of propofol by keeping BIS 40-60 throughout operation. Fentanyl is used for analgesia and atracurium is used for tracheal intubation.
bispectral index
Bispectral index (BIS) is one of several technologies used to monitor depth of anesthesia.
Target controlled infusion of propofol
TCI propofol (3-7 mcg/dL, Schnider model) is used for total intravenous anesthesia in both groups
Fentanyl
Fentanyl 1-2 mcg/kg iv for induction and then 0.5-1.0 mcg/kg/hr infusion is used for analgesic.
Atracurium
Atracurium 0.6 mg/kg is used for endotracheal intubation
clinical signs/TCI propofol/fentanyl
Clinical signs (heart rate, blood pressure and movement) guide target controlled infusion(TCI) of propofol. Fentanyl is used for analgesia and atracurium is used for tracheal intubation.
Target controlled infusion of propofol
TCI propofol (3-7 mcg/dL, Schnider model) is used for total intravenous anesthesia in both groups
Fentanyl
Fentanyl 1-2 mcg/kg iv for induction and then 0.5-1.0 mcg/kg/hr infusion is used for analgesic.
Atracurium
Atracurium 0.6 mg/kg is used for endotracheal intubation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bispectral index
Bispectral index (BIS) is one of several technologies used to monitor depth of anesthesia.
Target controlled infusion of propofol
TCI propofol (3-7 mcg/dL, Schnider model) is used for total intravenous anesthesia in both groups
Fentanyl
Fentanyl 1-2 mcg/kg iv for induction and then 0.5-1.0 mcg/kg/hr infusion is used for analgesic.
Atracurium
Atracurium 0.6 mg/kg is used for endotracheal intubation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA 1-3
* elective case
* cooperate patients
* Not receive drugs interfere with EEG
Exclusion Criteria
* liver disease
* propofol allergy
* BMI \> 30
* complete cord lesion
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manee Raksakietisak, MD
Role: PRINCIPAL_INVESTIGATOR
Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mahidol University, siriraj hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
099/2557
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.